Given the uncertainty over a mechanism by which KOR activity blunts MOR-mediated respiratory depression, future respiratory testing of mixed action ligands with MOR and KOR KO mice will be needed. The gene discussed is OPRM1; the disease is Respiratory insufficiency due to muscle weakness.